Reference
Scavone C, et al. Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study. BioDrugs : 20 Oct 2018. Available from: URL: http://doi.org/10.1007/s40259-018-0313-2
Rights and permissions
About this article
Cite this article
Safety evaluation of infliximab originator and biosimilars. Reactions Weekly 1727, 11 (2018). https://doi.org/10.1007/s40278-018-53996-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-53996-2